Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Senthil Sukumar

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Research and Practice in Thrombosis and Haemostasis|February 5, 2026
Optimizing the management of congenital thrombotic thrombocytopenic purpuraMelissa F Glasner, Senthil Sukumar, Spero R Cataland, et al.
Research and Practice in Thrombosis and Haemostasis|September 25, 2025
Standard cardiovascular risk prediction scores underestimate risk in immune-mediated thrombotic thrombocytopenic purpura survivorsBinish Javed, Jenna Brown, Jay Meade, et al.
Blood Advances|August 30, 2021
Cardiovascular disease is a leading cause of mortality among TTP survivors in clinical remissionSenthil Sukumar, Max Brodsky, Sarah Hussain, et al.
Journal of Medical Case Reports|December 29, 2019
Activating BRAF mutation in sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland: two case reports and review of the literatureJasmine S Sukumar, Senthil Sukumar, Darshana Purohit, et al.
Blood Advances|May 22, 2024
Recombinant ADAMTS13: an effective rescue therapy for acute cTTP during pregnancySimon Dadoun, Karolina Adam, Lisa Hensch, et al.
Blood|March 8, 2022
SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpuraHridaya Shah, Ann Kim, Senthil Sukumar, et al.
Journal of Clinical Medicine|February 13, 2025
Multicenter Prospective Pilot Study Identifying Thrombomodulin as a Potential Biomarker for Neurocognitive Outcomes in Immune Thrombotic Thrombocytopenic PurpuraAaron B Boothby, Michael D Evans, Shangbin Yang, et al.
Journal of Thrombosis and Haemostasis : JTH|April 19, 2025
Clonal hematopoiesis of indeterminate potential and incidence of venous thromboembolism in older adultsSeyedmohammad Saadatagah, Rock Bum Kim, Senthil Sukumar, et al.
American Journal of Hematology|August 30, 2021
Major adverse cardiovascular events in survivors of immune-mediated thrombotic thrombocytopenic purpuraMax A Brodsky, Senthil Sukumar, Sruthi Selvakumar, et al.
Expert Review of Hematology|June 8, 2026
A call to action for the use of composite hematologic measurements in hereditary hemorrhagic telangiectasia and other chronic bleeding disordersHanny Al-Samkari, Raj S Kasthuri, Jenny Y Zhou, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Research and Practice in Thrombosis and Haemostasis|February 5, 2026
Optimizing the management of congenital thrombotic thrombocytopenic purpuraMelissa F Glasner, Senthil Sukumar, Spero R Cataland, et al.
Research and Practice in Thrombosis and Haemostasis|September 25, 2025
Standard cardiovascular risk prediction scores underestimate risk in immune-mediated thrombotic thrombocytopenic purpura survivorsBinish Javed, Jenna Brown, Jay Meade, et al.
Blood Advances|August 30, 2021
Cardiovascular disease is a leading cause of mortality among TTP survivors in clinical remissionSenthil Sukumar, Max Brodsky, Sarah Hussain, et al.
Journal of Medical Case Reports|December 29, 2019
Activating BRAF mutation in sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland: two case reports and review of the literatureJasmine S Sukumar, Senthil Sukumar, Darshana Purohit, et al.
Blood Advances|May 22, 2024
Recombinant ADAMTS13: an effective rescue therapy for acute cTTP during pregnancySimon Dadoun, Karolina Adam, Lisa Hensch, et al.
Blood|March 8, 2022
SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpuraHridaya Shah, Ann Kim, Senthil Sukumar, et al.
Journal of Clinical Medicine|February 13, 2025
Multicenter Prospective Pilot Study Identifying Thrombomodulin as a Potential Biomarker for Neurocognitive Outcomes in Immune Thrombotic Thrombocytopenic PurpuraAaron B Boothby, Michael D Evans, Shangbin Yang, et al.
Journal of Thrombosis and Haemostasis : JTH|April 19, 2025
Clonal hematopoiesis of indeterminate potential and incidence of venous thromboembolism in older adultsSeyedmohammad Saadatagah, Rock Bum Kim, Senthil Sukumar, et al.
American Journal of Hematology|August 30, 2021
Major adverse cardiovascular events in survivors of immune-mediated thrombotic thrombocytopenic purpuraMax A Brodsky, Senthil Sukumar, Sruthi Selvakumar, et al.
Expert Review of Hematology|June 8, 2026
A call to action for the use of composite hematologic measurements in hereditary hemorrhagic telangiectasia and other chronic bleeding disordersHanny Al-Samkari, Raj S Kasthuri, Jenny Y Zhou, et al.
Pageof 3